Expert Interview
A Second View: Exploring JNJ's icotrokinra’s Phase 2 efficacy in treating difficult-to-treat scalp and genital psoriasis, and its potential place in the evolving psoriasis treatment landscape
Ticker(s): JNJInstitution: East Bay Psoriasis Center
- Director of Director East Bay Psoriasis Treatment Center
- Has participated in many studies involving Psoriasis, Eczema, Acne and Rosacea.
- Frequently lectures on the topics of Psoriasis, Inflammatory Skin disorders, Acne and Rosacea
Do you want answers to these questions?
Slingshot Insights Explained
- Call Date
- Jun 25, 2025
- Call Time
- 11:00 AM EDT
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
